102. [IF=8.5] Shengnan Wang et al."Postharvest changes in the phenolic and free volatile compound contents in Shine Muscat grapes at room temperature."FOOD CHEMISTRY.2025 Feb;465:141958 101. [IF=4.5] Shiyao Liao et al."Enhanced cartilage repair using gelatin methacryloyl hydrogels combined with icariin and magnesium-doped bioactive glass."Artificial Cells Nanomedicine and Biotechnology. 100. [IF=4.4] Chen Yangfeng et al."In Vitro evaluation of the anti-pancreatic cancer activity of epimedium herb."Frontiers in Pharmacology.2024 Jul;15: 99. [IF=0] Huiling Liu et al."High-strength double-network silk fibroin based hydrogel loaded with Icariin and BMSCs to inhibit osteoclasts and promote osteogenic differentiation to enhance bone repair."Biomaterials Advances".2024 Apr;:213856 98. [IF=1.7] Luo Wei et al."Icariin ameliorates viral myocarditis by inhibiting TLR4-mediated ferroptosis."Asian Pacific Journal of Tropical Biomedicine".2024 Mar;14(3):106 97. [IF=6] Dong Xie et al."Pharmacodynamic material basis and mechanism of Tenghuang Jiangu Wan on osteoarthritis using UPLC-Q-TOF-MS integrated with target network pharmacology."Arabian Journal of Chemistry".2024 Apr;17:105711 96. [IF=5.8] Zhao Mei et al."Icariin exerts anti-tumor activity by inducing autophagy via AMPK/mTOR/ULK1 pathway in triple-negative breast cancer."Cancer Cell International".2024 Dec;24(1):1-15 95. [IF=7.9] Yankai Dong et al."Effect of icariin on depressive behaviour in rat pups. Evidences for its mechanism of action by integrating network pharmacology, metabolomics and gut microbiota composition."PHYTOMEDICINE".2024 Apr;126:155422 94. [IF=5.4] Xinying Fu et al."Guhan Yangsheng Jing mitigates hippocampal neuronal pyroptotic injury and magnifies learning and memory capabilities in sleep deprived mice via the NLRP3/Caspase1/GSDMD signaling pathway."JOURNAL OF ETHNOPHARMACOLOGY".2024 Feb;:117972 93. [IF=8.4] Ting An et al."De novo biosynthesis of anticarcinogenic icariin in engineered yeast."METABOLIC ENGINEERING.2023 Nov;80:207 92. [IF=5.8] Xu Wenjing et al."Icariin-Curcumol promotes docetaxel sensitivity in prostate cancer through modulation of the PI3K-Akt signaling pathway and the Warburg effect."Cancer Cell International.10.1186/s12935-023-03042-1 91. [IF=8.2] Shaorong Li et al."Dual-functional 3D-printed porous bioactive scaffold enhanced bone repair by promoting osteogenesis and angiogenesis."Materials Today Bio.2024 Feb;24:100943 90. [IF=4.7] Xu Zhang et al."Rhein: A potent immunomodulator empowering largemouth bass against MSRV infection."FISH & SHELLFISH IMMUNOLOGY.2024 Jan;144:109284 89. [IF=1.7] Zhouyi Zhang et al."Revealing the differences in phenolics in different parts of Taraxacum mongolicum using UPLC-MS/MS."Phytochemistry Letters.2023 Aug;56:13 88. [IF=5.572] Zhen Zhao et al."An integrated strategy combining network toxicology and feature-based molecular networking for exploring hepatotoxic constituents and mechanism of Epimedii Folium-induced hepatotoxicity in vitro."FOOD AND CHEMICAL TOXICOLOGY.2023 Jun;176: 87. [IF=6.208] Jiaqi Zhang et al."The Effect of Epimedium Isopentenyl Flavonoids on the Broiler Gut Health Using Microbiomic and Metabolomic Analyses."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2023 Jan;24(8):7646 86. [IF=9.273] Jia Zeng et al."Bone Mesenchymal Stem Cell-derived Exosomes Involved Co-delivery and Synergism Effect with Icariin via Mussel-inspired Multifunctional Hydrogel for Cartilage Protection."Asian Journal of Pharmaceutical Sciences.2023 Mar;:100799 85. [IF=2.626] Ma, Rui-jiao et al."Kunxian Capsule Extract Inhibits Angiogenesis in Zebrafish Embryos via PI3K/AKT-MAPK-VEGF Pathway."Chinese Journal of Integrative Medicine.2022 Dec;:1-9 84. [IF=6.438] Wenjing Xu et al."Effects of icariin and curcumol on autophagy, ferroptosis, and lipid metabolism based on miR-7/m-TOR/SREBP1 pathway on prostate cancer."BIOFACTORS.2022 Dec;: 83. [IF=7.31] Mengxia Wang et al."Neuroprotective Mechanism of Icariin on Hypoxic Ischemic Brain Damage in Neonatal Mice."Oxidative Medicine and Cellular Longevity.2022 Nov 15;2022:1330928 82. [IF=1.698] Jinyan Wu et al."Chemical Identification and Antioxidant Screening of Bufei Yishen Formula using an Offline DPPH Ultrahigh-Performance Liquid Chromatography Q-Extractive Orbitrap MS/MS."International Journal of Analytical Chemistry.2022 Oct 15;2022:142380 81. [IF=3.571] Yuhao Zhang et al."A novel strategy integrating gas phase fractionation with staggered mass range and LC-MS/MS molecular network for comprehensive metabolites profiling of Gui Ling Ji in rats."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2023 Jan;222 80. [IF=5.738] Fu Yanjin et al."Icariin attenuates the tumor growth by targeting miR-1-3p/TNKS2/Wnt/β-catenin signaling axis in ovarian cancer."Frontiers in Oncology.2022 Sep;0:4742 79. [IF=6.208] Pan Wang et al."Discovery of Flavonoids as Novel Inhibitors of ATP Citrate Lyase: Structure–Activity Relationship and Inhibition Profiles."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2022 Jan;23(18):10747 78. [IF=5.895] Fang Liu et al."Co-Immobilizing Two Glycosidases Based on Cross-Linked Enzyme Aggregates to Enhance Enzymatic Properties for Achieving High Titer Icaritin Biosynthesis."JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY.2022;XXXX(XXX):XXX-XXX 77. [IF=5.988] Qihan Luo et al."Chang qing formula ameliorates colitis-associated colorectal cancer via suppressing IL-17/NF-κB/STAT3 pathway in mice as revealed by network pharmacology study."Frontiers in Pharmacology.2022; 13: 893231 76. [IF=6.064] Jia-Jun Huang et al."Computer-Aided Design of α-L-Rhamnosidase to Increase the Synthesis Efficiency of Icariside I."Frontiers in Bioengineering and Biotechnology.2022; 10: 926829 75. [IF=2.63] Li Hangchao et al."Bushen Jianpi Quyu Formula Alleviates Myelosuppression of an Immune-Mediated Aplastic Anemia Mouse Model via Inhibiting Expression of the PI3K/AKT/NF-κB Signaling Pathway."Evidence-based Complementary and Alternative Medicine. 2022;2022: 74. [IF=6.53] Pan Sun et al."Jiangu granule ameliorated OVX rats bone loss by modulating gut microbiota-SCFAs-Treg/Th17 axis."BIOMEDICINE & PHARMACOTHERAPY. 2022 Jun;150:112975 73. [IF=5.34] Dong Shao et al."Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology."PHYTOMEDICINE. 2022 Jul;102:154177 72. [IF=3.935] Junmao Li et al."Comprehensive chemical profiling of the flowers of Citrus aurantium L. var. amara Engl. and uncovering the active ingredients of lipid lowering."J Pharmaceut Biomed. 2022 Mar;211:114621 71. [IF=1.672] Yang Lihong et al."Bioactive molecule Icariin inhibited proliferation while enhanced apoptosis and autophagy of rat airway smooth muscle cells in vitro."Cytotechnology. 2019 Dec;71(6):1109-1120 70. [IF=1.902] Ting Zhang et al."The influence of essential oils from ZhaLi NuSi Prescription on the pharmacokinetics of its non-volatile components in normal rats."Biomedical Chromatography. 2021 Oct 21 69. [IF=1.986] Yang Du et al."Investigation of labile protein-ligand interactions by native electrospray ionization mass spectrometry."Int J Mass Spectrom. 2021 Apr;462:116524 68. [IF=2.447] Ling Sun et al."Icariin inhibits oral squamous cell carcinoma cell proliferation and induces apoptosis via inhibiting the NF?κB and PI3K/AKT pathways."Exp Ther Med. 2021 Sep;22(3):1-7 67. [IF=2.984] Xiao-Hua Yang et al."Flavonoids from Epimedium pubescens: extraction and mechanism, antioxidant capacity and effects on CAT and GSH-Px of Drosophila melanogaster."Peerj. 2020 Jan;8:e8361 66. [IF=3] Qu Lala et al."Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay."N-S Arch Pharmacol. 2020 Jun;393(6):937-950 65. [IF=3.361] Yuhao Zhang et al."An integrated approach for structural characterization of Gui Ling Ji by traveling wave ion mobility mass spectrometry and molecular network."Rsc Adv. 2021 Apr;11(26):15546-15556 64. [IF=3.645] Junfeng Li et al."An LC-MS/MS method for simultaneous quantification of 11 components of Xian-Xiong-Gu-Kang in the plasma of osteoarthritic rats and pharmacokinetic analysis."J Sep Sci. 2021 Sep;44(18):3386-3397 63. [IF=3.757] Congyan Liu et al."Enhanced hydrolysis and antitumor efficacy of Epimedium flavonoids mediated by immobilized snailase on silica."Process Biochem. 2019 Nov;86:80 62. [IF=3.765] Shun Liu et al."Simultaneous determination of seven effective components in Shenkui Tongmai granules based on UHPLC-MS/MS."J Pharm Pharmacol. 2021 Apr;73(6):758-766 61. [IF=4.36] Kun Shi et al."Epimedii Folium and Curculiginis Rhizoma ameliorate lipopolysaccharides-induced cognitive impairment by regulating the TREM2 signaling pathway."J Ethnopharmacol. 2022 Feb;284:114766 60. [IF=4.411] Zhenxian Qin et al."A Widely Metabolomic Analysis Revealed Metabolic Alterations of Epimedium Pubescens Leaves at Different Growth Stages."Molecules. 2020 Jan;25(1):137 59. [IF=4.432] Luya Pu et al."Icariin arrests cell cycle progression and induces cell apoptosis through the mitochondrial pathway in human fibroblast-like synoviocytes."Eur J Pharmacol. 2021 Dec;912:174585 58. [IF=5.34] Liping Zhang et al."Cardioprotective effect of icariin against myocardial fibrosis and its molecular mechanism in diabetic cardiomyopathy based on network pharmacology: Role of ICA in DCM."Phytomedicine. 2021 Oct;91:153607 57. [IF=2.419] Lu Wang et al."Characterization of interaction property of multi-components in Gardenia jasminoides with aldose reductase by microdialysis combined with liquid chromatography coupled to mass spectrometry."Rapid Communications In Mass Spectrometry. 2016 Au 56. [IF=3.935] Tong Wang et al."Metabolic profiling of icariin in rat feces, urine, bile and plasma after oral administration using ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry."J Pharmaceut Biomed. 2019 May;168:155 55. [IF=4.411] Tao Cheng et al."Comparative Pharmacokinetics Study of Icariin and Icariside II in Rats."Molecules. 2015 Dec;20(12):21274-21286 54. [IF=4.545] Yan-dan Zhou et al."Icariin ameliorates cisplatin-induced cytotoxicity in human embryonic kidney 293 cells by suppressing ROS-mediated PI3K/Akt pathway."Biomed Pharmacother. 2019 Jan;109:2309 53. [IF=5.64] Wu Dousheng et al."Oleanolic Acid Induces the Type III Secretion System of Ralstonia solanacearum."Front Microbiol. 2015 Dec;0:1466 52. [IF=6.529] Congyan Liu et al."Icariin combined with snailase shows improved intestinal hydrolysis and absorption in osteoporosis rats."Biomed Pharmacother. 2017 Oct;94:1048 51. Cheng, Tao, et al. "Comparative pharmacokinetics study of icariin and icariside II in rats." Molecules 20.12 (2015): 21274-21286.https://doi.org/10.3390/molecules201219763 50. Yang, Lihong, et al. "Bioactive molecule Icariin inhibited proliferation while enhanced apoptosis and autophagy of rat airway smooth muscle cells in vitro." Cytotechnology 71.6 (2019): 1109-1120.https://doi.org/10.1007/s10616-019-00348-9 49. Liu, Congyan, et al. "Icariin combined with snailase shows improved intestinal hydrolysis and absorption in osteoporosis rats."?Biomedicine & Pharmacotherapy?94 (2017): 1048-1056.https://doi.org/10.1016/j.biopha.2017.07.163 48. Jia, Xiaohe, et al. "Design, preparation, surface recognition properties, and characteristics of icariin molecularly imprinted polymers." Cogent Chemistry 1.1 (2015): 1059597. 47. Wang, Lu, et al. "Characterization of interaction property of multi‐components in Gardenia jasminoides with aldose reductase by microdialysis combined with liquid chromatography coupled to mass spectrometry." Rapid Communications in Mass Spectrometry 30 (2 46. Wang, Lu, et al. "Characterization of interaction property of multi‐components in Gardenia jasminoides with aldose reductase by microdialysis combined with liquid chromatography coupled to mass spectrometry." Rapid Communications in Mass Spectrometry 30 (2 45. 黃楷迪,劉敬霞,牛陽,馬學(xué)琴,張婷,卜凡淑,任慧,郭盛,錢大瑋,段金廒.回藥扎里奴思方UPLC指紋圖譜結(jié)合多成分含量測定的質(zhì)控方法研究[J].南京中醫(yī)藥大學(xué)學(xué)報(bào),2021,37(01):77-82. 44. 蘭海,劉欣妍,余玲,莫諾蘭,張燕,郭子右,吳清.大孔樹脂純化淫羊藿中朝藿定與淫羊藿苷工藝研究[J].中草藥,2020,51(17):4473-4481. 43. 劉聰燕,李瑞云,馬程遙,劉玉萍,瞿鼎,李曉琦,陳彥.殼聚糖交聯(lián)介孔二氧化硅固定化β-葡萄糖苷酶生物轉(zhuǎn)化淫羊藿苷研究[J].中草藥,2021,52(03):685-691. 42. 武通,陳東寧,許占江.基于VEGF/VEGFR-2信號(hào)通路研究淫羊藿苷促進(jìn)大鼠脛骨干骨折愈合的作用機(jī)制[J].浙江中醫(yī)藥大學(xué)學(xué)報(bào),2021,45(03):282-288+293. 41. 何俊慧,韋潔,李冬梅,何飛,陸國壽,韋冬梅,李懿,趙成堅(jiān),韋桂寧,李力.基于TLR4/NF-κB通路探討蛤蚧提取物對利血平誘導(dǎo)抑郁大鼠神經(jīng)炎癥的影響[J].中國實(shí)驗(yàn)方劑學(xué)雜志,2021,27(09):56-62. 40. 范小龍,陳冉,吳婉琴,劉國姣,黃坤,江豐.液相色譜串聯(lián)質(zhì)譜法測定食品中淫羊藿苷等20種功能成分[J].食品與機(jī)械,2021,37(01):86-93+98. 39. 李琦,孫貴才.淫羊藿苷對骨髓間充質(zhì)干細(xì)胞鐵死亡及向心肌樣細(xì)胞分化的影響[J].中國組織工程研究,2021,25(13):1988-1992. 38. 彭靜, 馬益華, 陳彥,等. 固定化蝸牛酶同時(shí)生物轉(zhuǎn)化淫羊藿中4種黃酮苷[J]. 中成藥, 2016, 38(9):1984-1990. 37. 張初瑜 陳素紅 吳素香. 一測多評(píng)法測定復(fù)方人參片中的8種苷類成分[J]. 中國現(xiàn)代應(yīng)用藥學(xué) 2018 35(05):90-96. 36. 高霞, 陳彥, 王瑩,等. 糊精濕法制粒對淫羊藿總黃酮酶解的影響[J]. 中成藥, 2014, 36(007):1392-1397. 35. 高霞, 劉璇, 陳彥,等. 淫羊藿總黃酮的生物轉(zhuǎn)化過程分析[J]. 中國中藥雜志, 2013, 38(23):4079. 34. 劉聰燕, 高霞, 陳彥,等. 淫羊藿總黃酮在骨質(zhì)疏松大鼠體內(nèi)的藥動(dòng)學(xué)行為[J]. 中成藥, 2017, 39(008):1595-1600. 33. 劉聰燕, 高霞, 黃萌萌,等. 淫羊藿總黃酮仿生酶解腸溶膠囊的制備及評(píng)價(jià)[J]. 中草藥, 2016(20). 32. 張燕. 大孔吸附樹脂分離純化淫羊藿EF5黃酮[J]. 北方藥學(xué), 2015, 000(011):11-13. 31. 劉聰燕 高霞 陳彥 等. 仿生酶解腸溶膠囊提高淫羊藿總黃酮口服生物利用度的可行性研究[J]. 中國醫(yī)藥工業(yè)雜志 2016(9期):1158-1164. 30. 楊成梓 范興 包俠萍 等. HPLC同時(shí)測定芪骨膠囊中5種成分的含量[J]. 中國實(shí)驗(yàn)方劑學(xué)雜志 2015 021(016):60-63. 29. 李婧,王英哲,劉玉翠,景志賢,閆莉,郭俊杰,姜大成,肖井雷.地理環(huán)境因子對朝鮮淫羊藿黃酮類成分空間分布影響的探測分析[J].中國中藥雜志,2019,44(24):5368-5374. 28. 王瑩 高霞 陳彥 等. 卡波姆對淫羊藿總黃酮酶解效果的影響[J]. 中國實(shí)驗(yàn)方劑學(xué)雜志 2014 20(009):1-5. 27. 范興, 楊成梓, 包俠萍,等. 芪骨膠囊HPLC指紋圖譜研究[J]. 中草藥, 2014, 045(009):1257-1261. 26. 涂艷, 熊莉娜, 柳湘潔,等. 淫羊藿苷對成骨細(xì)胞成骨分化的影響及Wnt/-catenin信號(hào)系統(tǒng)的關(guān)系研究[J]. 中國中醫(yī)急癥, 2017, 26(003):448-450. 25. 王藝璇 李海濤 劉順 等. 參葵通脈顆粒的質(zhì)量標(biāo)準(zhǔn)研究[J]. 中藥新藥與臨床藥理 2020年31卷8期 984-989頁 ISTIC PKU CSCD CA 2020. 24. 郭雙雙 鄭芳芳 可叢雪 等. 乳酸片球菌AS1.2696來源的α-L-鼠李糖苷酶酶學(xué)性質(zhì)分析[J]. 食品科學(xué) 2019 040(004):160-169. 23. 程素盼 張敏敏 梁琰 等. HPLC-DAD-ESI-TOF/MS法分析安神補(bǔ)腦液中化學(xué)成分[J]. 中成藥 2019 041(004):743-748. 22. 趙巖, 侯瑩瑩, 唐國勝,等. 炮制前后淫羊藿不同提取物對ACE、α-葡萄糖苷酶的抑制活性及對亞硝酸根的清除活性研究[J]. 藥物分析雜志, 2015(8期):1329-1334. 21. 劉玉萍, 丁學(xué)芳, 黃萌萌,等. 淫羊藿苷在不同骨質(zhì)疏松大鼠模型中腸道吸收代謝研究[J]. 中國中藥雜志, 2016(13):2532-2537. 20. 李瑞云 劉聰燕 許婷 等. 交聯(lián)納米SiO_2固定化蝸牛酶的制備表征及轉(zhuǎn)化淫羊藿苷研究[J]. 中草藥 2019 v.50;No.655(20):57-63. 19. 洪雅丹 張凌風(fēng) 潘娉娉 等. HPLC法同時(shí)測定淫羊藿-骨碎補(bǔ)藥對中7種成分[J]. 中成藥 2019 041(006):1316-1321. 18. 楊軼舜 張彤 丁越 等. 3種淫羊藿苷次生產(chǎn)物的制備及HPLC測定[J]. 中成藥 2020 042(003):779-782. 17. 何玉瓊, 趙璐, 沈燚,等. 淫羊藿苷對鐵超載模型小鼠骨代謝的影響[J]. 藥學(xué)學(xué)報(bào), 2018(7). 16. 楊芬, 劉彥禮, 閆巖,等. 淫羊藿苷對經(jīng)血源性子宮內(nèi)膜干細(xì)胞成心肌樣細(xì)胞分化的影響[J]. 中國細(xì)胞生物學(xué)學(xué)報(bào), 2016(11):1373-1381. 15. 鞠靜, 譚人千, 鐘勇,等. 淫羊藿苷對氣管切開模型大鼠早期β-防御素-2和T細(xì)胞亞群的影響[J]. 中南大學(xué)學(xué)報(bào):醫(yī)學(xué)版, 2020(1):1-7. 14. 鄧淑蓉, 潘宇政, 彭玲玲,等. 淫羊藿苷對氣管切開插管大鼠肺部肥大細(xì)胞活性及炎性反應(yīng)的影響[J]. 中華中醫(yī)藥雜志, 2018, 033(004):1594-1597. 13. 郭艷霞. 淫羊藿苷對去卵巢大鼠骨質(zhì)疏松癥的保護(hù)機(jī)制研究[J]. 四川中醫(yī), 2017, 035(007):63-65. 12. 朱彤彤, 黃連弟, 李俊瑋,等. 淫羊藿苷對去卵巢大鼠骨質(zhì)疏松癥的保護(hù)作用及其機(jī)制[J]. 吉林大學(xué)學(xué)報(bào)(醫(yī)學(xué)版), 2016, 42(005):915-919. 11. 周勇, 劉晶, 陳剛. 淫羊藿苷對D-半乳糖誘導(dǎo)的腦衰老模型小鼠皮層線粒體自噬的影響[J]. 中華中醫(yī)藥雜志, 2019, v.34(12):156-160. 10. 周勇,劉晶,陳剛.淫羊藿苷對D-半乳糖誘導(dǎo)的腦衰老模型小鼠p53/p21信號(hào)通路的影響[J].中華中醫(yī)藥學(xué)刊,2019,37(09):2159-2162+2316. 9. 鞠靜, 彭玲玲, 潘宇政,等. 淫羊藿苷及寶藿苷I對氣管切開模型大鼠肺組織病理學(xué)及炎癥因子的影響[J]. 中國實(shí)驗(yàn)動(dòng)物學(xué)報(bào), 2019, 27(3). 8. 徐永明, 徐宏光, 張曉玲,等. 淫羊藿素藥物在終板軟骨細(xì)胞退變中的保護(hù)作用研究[J]. 赤峰學(xué)院學(xué)報(bào)(自然版), 2016(16):54-57. 7. 林思文, 李雪芹, 劉素云,等. 淫羊藿素聯(lián)合阿霉素對人骨肉瘤MG-63細(xì)胞抑制作用的體外研究[J]. 中國中西醫(yī)結(jié)合雜志, 2016(36):0729-734. 6. 劉玉亮, 梁廣勝, 魏強(qiáng)強(qiáng),等. 淫羊藿總黃酮及淫羊藿素體外抗骨肉瘤的研究[J]. 中成藥, 2013, 35(010):2072-2077. 5. 彭靜, 馬益華, 陳彥,等. 微乳化-凝膠法制備微球固定化蝸牛酶并生物轉(zhuǎn)化淫羊藿苷研究[J]. 中草藥, 2015, 46(22):3326-3332. 4. 彭靜, 馬益華, 陳彥,等. 固定化β-葡萄糖苷酶和蝸牛酶生物轉(zhuǎn)化淫羊藿苷效率的比較研究[J]. 藥學(xué)學(xué)報(bào), 2015(12期):1652-1659. 3. 查琳 趙巖 祝洪艷 等. 人參莖葉總皂苷脂質(zhì)體與水溶液在大鼠體內(nèi)的血藥濃度及藥代動(dòng)力學(xué)參數(shù)對比分析[J]. 中國中藥雜志 2017(10). 2. 謝媛媛 彭靈 蘇加坤 等. 中藥淫羊藿薄層色譜鑒別方法的建立[J]. 中藥與臨床 2017(04):20-24. 1. 侯劍偉 丁越 張彤 等. HPLC-DAD法同時(shí)測定調(diào)更湯中3個(gè)活性成分[J]. 中成藥 2014 36(7):1454-1457.